pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·4h ago·1 min read
save

U.S. experts to evaluate if measles elimination status still holds amid rising cases

Aug 6, 2026·read at STAT ↗Negative

Noel T. Brewer, chair of the U.S. National Verification Committee, explains that his group will review the CDC’s annual measles report to decide if the United States continues to meet elimination criteria.

The committee’s role is to independently certify the CDC findings and forward its opinion to the Regional Verification Commission, a process that has been in place since the country achieved elimination in 2000.

This year, the U.S. has already recorded more measles cases than in all of 2025, highlighting how quickly a public‑health success can be threatened.

The upcoming assessment will determine whether the nation retains its elimination status or faces the prospect of losing it, underscoring the need for continued vigilance.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: What my colleagues and I will look for as we assess U.S. measles elimination status”

read at STAT ↗
1,295 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Vaccines2ImmunologyInfectious DiseaseType 2 DiabetesVaccine

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 25Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugsSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Ratio rounds up $70M; Crystalys culls $130MFierce Biotech
  • 23h agoPfizer ramps up ongoing restructuring, Lisata axes 72% of staffBioSpace
  • 6d agoOpinion: What a recent op-ed got wrong about our Covid studySTAT